Beximco Pharma launches oral Covid-19 drug

Beximco Pharmaceuticals has launched the first ever oral antiviral drug for symptomatic Covid-19 is known as generic molnupiravir.

Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir in the country.

Chief Operating Officer of Beximco Pharmaceuticals Rabbur Reza confirmed this on Tuesday noon.

Managing Director of Beximco Pharmaceuticals Nazmul Hassan Papon said, “Further to our launch of the first generic remdesivir at the start of the pandemic, the launch of a generic version of molnupiravir, the world's first oral antiviral drug to treat Covid-19, is another example of Beximco Pharma's ability to rapidly respond to make affordable treatments available to patients suffering from Covid-19.”
 

The price of per capsule has been fixed at Tk 70. As per the advice of doctors, Covid-19 infected people aged over 18 years will have to take 40 pills to prevent infection.